Still corroborating the role of GLUT1 as a predictive marker in a meta-analysis, Zhao et al.44 analyzed 41 studies with a total of 4797 patients, in whom increased GLUT1 expression was significantly associated with worse prognosis in different types of cancer. This evidence concerns the gene SLC2A1 and cancer.